Role of VEGF-flt receptor system in normal and tumor angiogenesis.
about
A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cellsA novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinasesProteolytic processing regulates receptor specificity and activity of VEGF-C.Expression of Placenta growth factor (PlGF) in non-small cell lung cancer (NSCLC) and the clinical and prognostic significanceEffect of VEGF receptor inhibitor PTK787/ZK222584 [correction of ZK222548] combined with ionizing radiation on endothelial cells and tumour growthFlt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in miceAnti-SPARC oligopeptide inhibits laser-induced CNV in mice.Expression of Angiogenic Factors in Psoriasis VulgarisMolecular diversity of VEGF-A as a regulator of its biological activity.HIF-1α regulated tongue squamous cell carcinoma cell growth via regulating VEGF expression in a xenograft modelThe vascular-ablative agent VEGF(121)/rGel inhibits pulmonary metastases of MDA-MB-231 breast tumors.Inhibition of prostate cancer osteoblastic progression with VEGF121/rGel, a single agent targeting osteoblasts, osteoclasts, and tumor neovasculature.Tyrosine Kinase Receptor Flt/VEGFR Family: Its Characterization Related to Angiogenesis and Cancer.The vascular-targeting fusion toxin VEGF121/rGel inhibits the growth of orthotopic human bladder carcinoma tumors.Hypoxia-inducible factor 1 alpha and vascular endothelial growth factor overexpression in ischemic colitisExpression and prognostic relevance of vascular endothelial growth factor (VEGF) and its receptor (FLT-1) in nephroblastoma.VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer.A Switch in the Dynamics of Intra-Platelet VEGF-A from Cancer to the Later Phase of Liver Regeneration after Partial Hepatectomy in Humans.Vascular Endothelial Growth Factor (VEGF) and Its Receptor (VEGFR) Signaling in Angiogenesis: A Crucial Target for Anti- and Pro-Angiogenic TherapiesCell-surface perturbations of the epidermal growth factor and vascular endothelial growth factor receptors by phosphorothioate oligodeoxynucleotidesDifferentiation of stem cells upon deprivation of exogenous FGF2: a general approach to study spontaneous differentiation of hESCs in vitro.Expression of vascular endothelial growth factor mRNA in non-small-cell lung carcinomasCo-expression of vascular endothelial growth factor (VEGF) and its receptors (flk-1 and flt-1) in hormone-induced mammary cancer in the Noble ratInhibition of breast cancer growth in vivo by antiangiogenesis gene therapy with adenovirus-mediated antisense-VEGFA high vascular count and overexpression of vascular endothelial growth factor are associated with unfavourable prognosis in operated small cell lung carcinoma.Phase I clinical trial of human vascular endothelial growth factor receptor 1 peptide vaccines for patients with metastatic renal cell carcinoma.Ligand-dependent development of the endothelial and hemopoietic lineages from embryonic mesodermal cells expressing vascular endothelial growth factor receptor 2.Delineation of VEGF-regulated genes and functions in the cervix of pregnant rodents by DNA microarray analysis.VEGFR and type-V RTK activation and signalingThe levels of circulating vascular endothelial growth factor and soluble Flt-1 in pregnancies complicated by preeclampsia.Anti-angiogenesis approach to genitourinary cancer treatment.In vivo angiogenic activity and hypoxia induction of heterodimers of placenta growth factor/vascular endothelial growth factorNitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells.Angiogenesis drives psoriasis pathogenesis.Characterization of the extracellular domain in vascular endothelial growth factor receptor-1 (Flt-1 tyrosine kinase).VEGF involvement in psoriasis.Site-Specific N-Glycosylation of Endothelial Cell Receptor Tyrosine Kinase VEGFR-2.The effects of HIF-1alpha on gene expression profiles of NCI-H446 human small cell lung cancer cellsTreatment of metastatic colorectal carcinomas by systemic inhibition of vascular endothelial growth factor signaling in miceThe second immunoglobulin-like domain of the VEGF tyrosine kinase receptor Flt-1 determines ligand binding and may initiate a signal transduction cascade
P2860
Q24291278-367ADB88-9B61-4221-BCE4-29030F7E1500Q24336293-5DB0F5DC-834E-4190-8700-919BB68EC857Q24532314-CE219F25-3500-40F8-9B4F-25AB1DC3D565Q24813132-C75D274B-9F9E-4C8A-911D-9E9B3255B77DQ28366604-0D27B6EE-0000-4E3E-896D-5806D9DF2743Q28504776-E0C0AD6D-2682-40C0-86DA-570FDB2F72CDQ33518165-869E1CDB-FD25-4DB6-A1CA-760157223643Q33666312-6D7E75C4-2C3B-4E02-91BF-AA5F50927FB2Q34089123-EFA46A15-9FE7-4D83-8CEF-71074E5532A6Q34385121-229BACE8-94CB-4262-AABA-CEFE35C405C2Q34768492-1C249C99-A131-4D84-AAC2-CBD11E0B60B3Q34809729-767032CD-0756-43C2-8F73-13F1D0AFE74CQ34972727-0F3F9F54-BB5E-4E20-9F32-8CEE3069545AQ34997320-1B243271-EB3E-494F-932E-87C8D976250BQ35010460-6070B886-70E4-49FA-9FBE-C23815E3E900Q35586613-8807E901-7C4D-4FA5-BD62-202E204D644DQ35786920-74E695C0-C5E5-4F8C-BCD2-64209C799E67Q35940940-A15E7FA2-4CF2-402C-B5A3-98757B6F1F3CQ36137701-236D31DD-FBC0-429E-810C-7AC1720B074CQ36192928-F66B55F5-A816-4343-9249-02887C556F52Q36425858-A1DE5B6E-9A9A-4906-9D40-45067E936B1FQ36617389-2E2B3B54-93B5-4F16-87B0-8D081E330682Q36620026-CFBB487D-4957-4469-8AFA-17ABFC72401DQ36623011-79004B7B-1899-4E26-865B-7A1941A8A91EQ36644123-A4B8AD73-349C-4BD7-8D0A-136B988DB46FQ36747387-B16CA9A0-E228-496D-BE2E-1B58CC2000E4Q36766439-FD4B2A06-E06C-4140-8454-8D5EF71FB1EBQ37067054-FA0C43AD-29F1-4BC5-8204-09C0E9EF96E4Q37197494-5330F35F-FEAB-4335-818F-6482FCE69864Q37220296-CE1A6A7D-BA9F-4222-8D94-B2EB824F562BQ37354411-1ECCAFD1-FD64-49B9-8599-6B9576756F8BQ37361775-230D7DC3-6108-4C06-B305-5F7376D1C1F7Q37376612-22E250AF-2C3C-4045-9D8A-DCC851F1CA07Q37534974-4CBD9E52-9E65-40F2-A877-AE231DD7CB57Q38341686-27FCCC74-1976-488D-8A03-6F10B7C02298Q38648336-2EE595CA-80BC-4B56-9C34-52B39758E837Q39102302-CE0B269B-645F-41B2-A93F-2BD9A78548A6Q39764749-7320F9F6-F12B-41F7-98F6-CEDE997473D7Q40394572-20F2EC62-ED3B-4CB5-8D72-D065614CEDEBQ41077200-FDA1C7DB-D5F8-405B-AC78-EC3B99B634FB
P2860
Role of VEGF-flt receptor system in normal and tumor angiogenesis.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Role of VEGF-flt receptor system in normal and tumor angiogenesis.
@en
type
label
Role of VEGF-flt receptor system in normal and tumor angiogenesis.
@en
prefLabel
Role of VEGF-flt receptor system in normal and tumor angiogenesis.
@en
P1476
Role of VEGF-flt receptor system in normal and tumor angiogenesis
@en
P2093
P304
P577
1995-01-01T00:00:00Z